Yamamoto Y, Iwata H, Saji S, Takahashi M, et al. Erratum: Pertuzumab Retreatment for Human Epidermal Growth Factor Receptor 2-Positive Locally Advanced/Metastatic Breast Cancer (PRECIOUS Study): Final Overall Survival Analysis. J Clin Oncol 2025 Apr 11:JCO2500722. doi: 10.1200/JCO-25-00722.
PMID: 40215433